Search Results - "Vail, David"

Prospects for a Rim County Renaissance: Pandemic as Economic Opportunity by Vail, David

Get full text

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats by LeBlanc, Amy K., Atherton, Matthew, Bentley, R. Timothy, Boudreau, C. Elizabeth, Burton, Jenna H., Curran, Kaitlin M., Dow, Steven, Giuffrida, Michelle A., Kellihan, Heidi B., Mason, Nicola J., Oblak, Michelle, Selmic, Laura E., Selting, Kimberly A., Singh, Ameet, Tjostheim, Sonja, Vail, David M., Weishaar, Kristen M., Berger, Erika P., Rossmeisl, John H., Mazcko, Christina

“…The updated VCOG‐CTCAE v2 guidelines contain several important updates and additions since the last update (v1.1) was released in 2011 and published within…”
Get full text

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting by Magee, Kara, Marsh, Ian R, Turek, Michelle M, Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Kurzman, Ilene D, Zuleger, Cindy L, Oseid, Elizabeth A, Jaskowiak, Christine, Albertini, Mark R, Esbona, Karla, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey P, Morris, Zachary S, Hernandez, Reinier, Vail, David M

“…Murine syngeneic tumor models have revealed efficacious systemic antitumor responses following primary tumor in situ vaccination combined with targeted…”
Get full text

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade by Patel, Ravi B, Hernandez, Reinier, Carlson, Peter, Grudzinski, Joseph, Bates, Amber M, Jagodinsky, Justin C, Erbe, Amy, Marsh, Ian R, Arthur, Ian, Aluicio-Sarduy, Eduardo, Sriramaneni, Raghava N, Jin, Won Jong, Massey, Christopher, Rakhmilevich, Alexander L, Vail, David, Engle, Johnathan W, Le, Trang, Kim, KyungMann, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey, Morris, Zachary S

“…Molecular and cellular effects of radiotherapy on tumor microenvironment (TME) can help prime and propagate antitumor immunity. We hypothesized that delivering…”
Get more information

Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer by Ghaghada, Ketan B, Sato, Amy F, Starosolski, Zbigniew A, Berg, John, Vail, David M

“…Companion dogs with naturally occurring cancer serve as an important large animal model in translational research because they share strong similarities with…”
Get full text

Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL) by Mudaliar, Manikhandan A V, Haggart, Ross D, Miele, Gino, Sellar, Grant, Tan, Karen A L, Goodlad, John R, Milne, Elspeth, Vail, David M, Kurzman, Ilene, Crowther, Daniel, Argyle, David J

“…We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the…”
Get full text

A comparison of 12‐ and 19‐week CHOP protocols using non‐randomized, contemporaneous controls by Vos, Nathaniel, Pellin, MacKenzie, Vail, David M.

“…This study is a concurrent comparison of two versions of CHOP protocols, a 19‐week CHOP and a comparatively overall dose‐intense 12‐week CHOP. The 12‐week…”
Get full text

Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial by Takada, Marilia, Kitagawa, Keita, Zhang, Yongzhen, Bulitta, Jürgen B., Moirano, Steven, Jones, Abigail, Borgen, Jennifer, Onsager, Ashley, Thaiwong, Tuddow, Vail, David M.

“…ABSTRACT MAPK has been reported as a key oncogenic pathway for canine histiocytic sarcoma, which can be pharmacologically targeted with trametinib, a small…”
Get full text

Invited Essay: Field Notes: Exploring the STEM-Humanities History of Nebraska's Agriculture: Expanded Remarks for the 2018 Warner Lecture by Vail, David D

Get full text

Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology by LeBlanc, Amy K, Breen, Matthew, Choyke, Peter, Dewhirst, Mark, Fan, Timothy M, Gustafson, Daniel L, Helman, Lee J, Kastan, Michael B, Knapp, Deborah W, Levin, Wendy J, London, Cheryl, Mason, Nicola, Mazcko, Christina, Olson, Patricia N, Page, Rodney, Teicher, Beverly A, Thamm, Douglas H, Trent, Jeffrey M, Vail, David M, Khanna, Chand

Get more information

Development of a next-generation sequencing protocol for the canine T cell receptor beta chain repertoire by Zuleger, Cindy L, Schwartz, Rene Welch, Ong, Irene M, Newton, Michael A, Vail, David M, Albertini, Mark R

“…Profiling the T cell receptor (TCR) repertoire using next-generation sequencing has become common in both human and translational research. Companion dogs with…”
Get full text

Short survival time following palliative‐intent hypofractionated radiotherapy for non‐resectable canine thyroid carcinoma: A retrospective analysis of 20 dogs by Tsimbas, Kathleen, Turek, Michelle, Christensen, Neil, Vail, David M., Forrest, Lisa

“…Radiotherapy is the treatment of choice for non‐resectable canine thyroid carcinoma. High tumor response rates and median survival times of 2 years or longer…”
Get full text

Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs by Paoloni, Melissa C, Mazcko, Christina, Fox, Elizabeth, Fan, Timothy, Lana, Susan, Kisseberth, William, Vail, David M, Nuckolls, Kaylee, Osborne, Tanasa, Yalkowsy, Samuel, Gustafson, Daniel, Yu, Yunkai, Cao, Liang, Khanna, Chand

“…Signaling through the mTOR pathway contributes to growth, progression and chemoresistance of several cancers. Accordingly, inhibitors have been developed as…”
Get full text

Advanced Cancer Imaging Applied in the Comparative Setting by Vail, David M, LeBlanc, Amy K, Jeraj, Robert

“…The potential for companion (pet) species with spontaneously arising tumors to act as surrogates for preclinical development of advanced cancer imaging…”
Get full text

Farming across Borders: A Transnational History of the North American West ed. by Sterling Evans (review) by Vail, David D

Get full text

Farming by Rail: Demonstration Trains and the Rise of Mobile Agricultural Science in the Great Plains by VAIL, DAVID D.

“…In the early 1900s, railroad companies throughout the Great Plains worked with agricultural extension personnel and land-grant colleges to design demonstration…”
Get full text

Guiding the Optimal Translation of New Cancer Treatments From Canine to Human Cancer Patients by KHANNA, Chand, LONDON, Cheryl, VAIL, David, MAZCKO, Christina, HIRSCHFELD, Steven

“…On June 20, 2008, a meeting entitled “Translation of new cancer treatments from canine to human cancer patients,” sponsored by the National Cancer Institute in…”
Get full text

Patterns of local residual disease and local failure after intensity modulated/image guided radiation therapy for sinonasal tumors in dogs by Poirier, Valerie J., Koh, Ethel S. Y., Darko, Johnson, Fleck, Andre, Pinard, Christopher, Vail, David M.

“…Background Most dogs with sinonasal tumors (SNT) treated with radiation therapy (RT) died because of local disease progression. Hypothesis/Objectives Our…”
Get full text

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma by Albertini, Mark R, Zuleger, Cindy L, Ranheim, Erik A, Shiyanbola, Oyewale, Sondel, Paul M, Morris, Zachary S, Eickhoff, Jens, Newton, Michael A, Ong, Irene M, Schwartz, Rene Welch, Hayim, Rubi, Kurzman, Ilene D, Turek, Michelle, Vail, David M

“…Canine malignant melanoma provides a clinically relevant, large animal parallel patient population to study the GD2-reactive hu14.18-IL-2 immunocytokine as it…”
Get full text

Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs by Cawley, Jacob R., Wright, Zachary M., Meleo, Karri, Post, Gerald S., Clifford, Craig A., Vickery, Kathryn R., Vail, David M., Bergman, Philip J., Thamm, Douglas H.

“…Background Rabacfosadine (RAB), a novel antineoplastic agent conditionally licensed for the treatment of lymphoma in dogs, is efficacious in both naïve and…”
Get full text